Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin

Vaccine

Volumn 14, Issue 12, 1996, Pages 1167-1173

  Fló, Juan ^a   Goldman, Hebe ^a   Roux, María E ^b   Massouh, Ernesto ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Bacterial immunomodulator; Cholera toxin; Immune response

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A; IMMUNOMODULATING AGENT; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHOLERA; CONTROLLED STUDY; IMMUNOGENICITY; IMMUNOMODULATION; INTESTINE MUCOSA; LUNG LAVAGE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL; RAT;

EID: 0030581356     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(96)00019-9     Document Type: Article

References (37)

1. 1 McGhee, J.R. and Kiyono, H. New perspectives in vaccine development: mucosal immunity to infections. Infect. Agents Dis. 1993, 2, 55-73
2. 2 Husband, A.J. Novel vaccination strategies for the control of mucosal infection. Vaccine 1993, 11, 107-112
3. 3 Elson, C.O. and Ealding, W. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immun. 1984, 132, 2736-2741
4. 4 Lycke, N. and Holmgren, J. Intestinal mucosal memory and presence of memory cells in lamina propria and peyer's patches in mice 2 years after oral immunization with cholera toxin. Scand. J. Immun. 1986, 23, 611-616
5. 5 Lycke, N. and Holmgren, J. Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization. Scand. J. Immun. 1987, 25, 407-412
6. 6 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308
7. 7 Elson, C.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immun. 1984, 133, 2892-2897
8. 8 Lycke, N., Takao, T. and Holmgren, J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immun. 1992, 22, 2277-2281
9. 9 Sultzer, B.M. and Goodman, G.W. Endotoxin protein: a B cell mitogen and polyclonal acgtivator of C3H/HeJ lymphocytes. J. Exp. Med. 1976, 144, 821-827
10. 10 Jacobs, D.M. Synergy between T cell-replacing factor and bacterial lipopolysaccharide (LPS) in the primary antibody response in vitro: a model of lipopolysacharide adjuvant action. J. Immun. 1979, 122, 1421-1426
11. 11 Jacobs, D.M. Lipopolysaccharide and the immune response. Recent Advances in Mucosal Immunology (Eds Strober, W., Hanson, L.A. and Sell, K.W.). Raven Press, New York, 1982, pp. 47-55
12. 12 Louis, J.A., Chiller, J.M. and Weigle, W.O. The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. J. Exp. Med. 1973, 138, 148
13. 13 Beagley, W.K., Eldridge, W.J., Kiyono, H. et al. Recombinanat Murine IL-5 induces high rate IgA synthesis in cycling IgA positive Peyer's patch B cells. J. Immun. 1988, 141, 2035-2042
14. 14 Coffman, R.L., Deborah, A.L. and Shrader, B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 1989, 170, 1039-1044
15. 15 Lebman Deborah, A. and Coffman Robert, L. The effect of IL-4 and IL-5 on the IgA response by murine peyer's patch B cell subpopulations. J. Immun. 1988, 141, 2050-2056
16. 16 Cebra, J.J., Cebra, E.R., Clough, E.R. et al. IgA commitment: modes for B cell differentiation and possible rol of T cells in regulating B cell development. Ann. NY Acad. Sci. 1983, 409, 25-37
17. 17 Kiyono, H., McGhee, J.R., Kearney, J.F. and Michalek, S.M. Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide. Scand. J. Immun. 1982, 15, 329-339
18. 18 Babb, J.L., Kiyono, H., Michalek, S.M. and McGhee, J.R. LPS regulation of the immune response: suppression of immune responses to orally administered T-independent antigen. J. Immun. 1981, 127, 1052-1057
19. 19 McGhee, J.R., Michalek, S.M., Kiyono, H., Babb, J.L. Clark, M.P. and Mosteller, L.M. Lipopolysaccharide regulation of the IgA immune response. Recent Advances in Mucosal Immunology (Eds Strober, W., Hanson, L.A. and Sell, K.W.). Raven Press, New York, 1982, 57-72
20. 20 Ruedl, C., Albini, B., Bock, G., Wick, G. and Wolf, H. Oral administration of a bacterial immunomodulator enhances murine intestinal lamina propria and peyer patch lymphocyte traffic to the lung - possible implications for infectious disease prophylaxis and therapy. Int. Immun. 1993, 5, 29-36
21. 21 Gonzalez Ariki, S., Christensen, F. and Roux, M.E. Efectos del inmunomodulador 104 sobre la población linfocitaria de la mucosa intestinal de ratas inmunodeficientes. Immunología 1993, 12, 59-63
22. 22 Elson, C.O., Ealding, W. and Lefkowitz, J. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J. Immun. Meth. 1984, 67, 101-108
23. 23 Lycke, N., Lindhom, L. and Holmgren, J. Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice. Clin. Exp. Immun. 1985, 62, 39-47
24. 24 Czerkinsky, C.C., Nilsson, L., Nygren, H., Ouchterlony, O. and Tarkowski, A. A solid-phase enzime-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immun. Meth. 1983, 65, 109-121
25. 25 Craig, S.W. and Cebra, J.J. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 1971, 134, 18
26. 26 Cebra, J.J., Gearhart, P.J., Kamat, R., Robertson, S.M. and Tseng, J. Origin and differentiation of lymphocytes involved in the secretory IgA response. In Cold Spring Harbor Symp. Quantitative Biol. 1976, 41, 215
27. 27 Cebra, J.J., Gearhart, P.J., Hajsey, J.F., Hurwitz, J.L. and Shahin, R.D. Role of environmental antigens in the ontogeny of the secretory immune response. J. Reticuloendothel. Soc. 1980, 28, 61s
28. 28 McWilliams, M., Phillips-Quagliata, J.M. and Lamm, M.F. Characteristics of mesenteric lymph node cells homing to gut-associated lymphoid tissue in syngeneic mice. J. Immun. 1975, 115, 54-61
29. 29 McWillams, M., Phillips-Quagliata, J.M. and Lamm, M.E. Mesenteric lymph node B lymphoblasts wich home to the small intestine are precommitted to IgA synthesis. J. Exp. Med. 1977, 145, 866-875
30. 30 Hill, S.J. and Ebersole, J.L. Cholera toxin synergizes LPS-and IL-1β-induced PGE2 release: potential amplification systems in cholera. Lymphokine Cytokine Res. 1991, 10, 449-455
31. 31 Pierce, N.F., Sacci, J.B., Alving, C.R. and Richardson, E.C. Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin. Rev. Infect. Dis. 1984, 6, 563-566
32. 32 Elson, C.O. Cholera toxin as a mucosal adjuvant - effects of H-2 major histocompatibility complex and LPS genes. Infect. Immun. 1992, 60, 2874-2879
33. 33 Persson, U. Lipopolysaccharide-induced supression of the primary immune response to a thymus-dependent antigen. J. Immun. 1977, 118, 789
34. 34 Uchiyama, T. and Jacobs, D.M. Modulation of the immune response by bacterial lipopolysaccharide (LPS): cellular basis of stimulatory and inhibitory effects of LPS on the in vitro IgM antibody response to a T-dependent antigen. J. Immun. 1978, 121, 2347
35. 35 Uchiyama, T. and Jacobs, D.M. Modulation of immune response by bacterial lipopolysaccharide (LPS): multifocal effects of LPS-induced supression of the primary antibody response to a T-dependent antigen. J. Immun. 1978, 121, 2340
36. 36 Michalek, S.M., Kiyono, H., Wannemuehler, M.L., Mosteller, L.M., and McGhee, J.R. Lipopolysaccharide (LPS) regulation of the immune response. LPS influence on oral tolerance induction. J. Immun. 1982, 128, 1192
37. 37 Elson, C.O., Holland, S.P., Dertzbaugh, M.T., Cuff, C.F. and Anderson, A.O. Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J. Immun. 1995, 154, 1032-1040